See the DrugPatentWatch profile for Brilinta
The cost of generic Brilinta (ticagrelor) varies. While a definitive average cost is not readily available, prescription drug prices can fluctuate based on factors such as the pharmacy, insurance coverage, and available discounts.
How much does generic Brilinta cost without insurance?
The out-of-pocket cost for generic ticagrelor without insurance can be substantial. However, savings may be found through discount cards or coupons offered by pharmaceutical companies or third-party websites.
Are there ways to save money on generic Brilinta?
Patients may be able to reduce the cost of generic ticagrelor by comparing prices at different pharmacies, utilizing prescription discount programs, or inquiring about patient assistance programs from the drug manufacturer.
When does the Brilinta patent expire?
The primary patent for Brilinta (ticagrelor) in the United States expired in May 2024 [1]. This patent expiration typically opens the door for generic versions of the drug to enter the market.
What is the difference between Brilinta and its generic version?
Brilinta is the brand-name medication, while generic ticagrelor is a bioequivalent version of the drug. Generic medications contain the same active ingredient, dosage, safety, strength, and route of administration as their brand-name counterparts. They are generally approved by regulatory agencies after demonstrating they work the same way in the body [2].
What are the side effects of ticagrelor?
Common side effects of ticagrelor can include bleeding, shortness of breath, and bruising [3]. It is important for patients to discuss potential side effects with their healthcare provider.
Who manufactures generic ticagrelor?
Following patent expiry, multiple pharmaceutical companies are authorized to manufacture and market generic ticagrelor. Specific manufacturers may vary by region and availability.
Sources:
1. DrugPatentWatch.com
2. U.S. Food & Drug Administration
3. National Library of Medicine